Fagio spray helps quickly relieve local irritation, itching, and discomfort; it is an easy and effective solution.
Pyobacteriophagum liquidum
Antibacterial agents → Bacteriophage
A transparent yellow liquid with varying intensity and a specific taste.
Active ingredients:
Each 1 mL of the preparation contains sterile filtrates of bacteriophages targeting bacteria: Streptococcus, Staphylococcus, E. coli, Pseudomonas aeruginosa, Proteus. Each phage titer is ≥ 1×10⁵.
Pharmaceutical form:
20 mL sterile solution for oral (per os), rectal (per rectum), local, or topical use.
Pharmacotherapeutic group:
Specific antibacterial agent
Phagio® is used for the prophylaxis and treatment of purulent bacterial infections in patients of all ages and high-risk groups.
For treatment:
Upper and lower respiratory tract bacterial infections (rhinitis and sinusitis, otitis media, tonsillitis, laryngitis, tracheitis, bronchitis, pneumonia, pleuritis)
Surgical practice: infected wounds, burns, abscesses, phlegmons, furuncles, carbuncles, hidradenitis, paronychia, paraproctitis, mastitis, bursitis, osteomyelitis (as part of complex therapy)
Urological practice: urogenital infections (urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis)
Gastrointestinal infections (enteric infections, gastroenterocolitis, cholecystitis, irritable bowel syndrome with dysbacteriosis)
Neonatal purulent-inflammatory diseases (omphalitis, pyoderma, sepsis)
Other infections caused by the indicated microorganisms
In sepsis, Phagio® in complex therapy enhances treatment effectiveness
For prophylaxis:
Treatment of new wounds in both hospital and home settings
Prevention of purulent complications during surgical procedures and manipulations
Prevention of purulent complications in acute respiratory viral infections
Prevention of bacterial contamination and nosocomial infections in medical institutions
Hypersensitivity to any component of the preparation
One of the key factors for effective phage therapy is determining the sensitivity of the causative microorganism to the phages contained in the preparation
Particularly effective when used at an early stage of infection and directly at the site of infection
Prescribed by a physician:
Orally (per os), rectally (per rectum)
Locally (as washes, dressings, or tampons)
Introduced into cavities (wounds, abscesses, pleural cavity, joints, nose and paranasal sinuses, ear, urinary bladder, vagina/uterus)
For local purulent-inflammatory processes: use both locally and orally simultaneously
Treatment duration: typically 5–10 days
Dosage depends on the size or volume of the affected area
For infected cavities, the preparation is introduced after drainage of pus under sterile conditions
The procedure is performed once daily for 3–5 days
